Browse by Poster Presenter

Type here to filter the list

A
AA Machado, Marina

McGill University Health Center
(P-524) Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis
Marina AA Machado
Favorite
(P-525) Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
Marina AA Machado
Favorite
Aakj�r, Mia

University of Copenhagen
(P-632) Comparison of the Incidence of Acute Pancreatitis Among New Users of Fluoxetine, Citalopram, and Other Selective Serotonin Reuptake Inhibitors: A Danish Register-based Cohort Study
Mia Aakj�r
Favorite
Abdelaziz, Nourhan

Faculty of Pharmacy, Alexandria University - Egypt
(P-557) Survival Analysis of ICU Patients Administered Human Albumin Infusion from the MIMIC III v1.4 Database
Nourhan Abdelaziz
Favorite
Abdelwahab, Ghada

Faculty of Pharmacy, Isra University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Ghada Abdelwahab
Favorite
Abdulah, Rizky

University of Padjadjaran
(P-058) Process Evaluation of Implementing a Pharmacist-led Intervention to Improve Adherence to Antihypertensive Drugs Among Patients with Type 2 Diabetes in Indonesian Community Health Centers
Rizky Abdulah
Favorite
Aben, Katja

Netherlands Comprehensive Cancer Organisation
(P-486) Diabetes Medication Use Is Associated with Higher Grade and Increased Probability of Muscle-invasive Tumour Disease in Patients with Urothelial Carcinoma
Katja Aben
Favorite
Aberle, Jens

Universitäres Adipositas Centrum
(P-335) Pilot Study Rectifies Real World Study Design to Support Regulatory Decision Making
Jens Aberle
Favorite
Abner, Erin

University of Kentucky
(P-246) An Evaluation of Injurious Falls and Fall-risk-increasing-drug (FRID) Prescribing Behaviors in a Nationally Representative Sample & the Pharmacist’s Role in Fall Prevention
Erin Abner
Favorite
Abrahamowicz, Michal

McGill University
(P-525) Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
Michal Abrahamowicz
Favorite
Absalon, Judith

Pfizer
(P-269) A Descriptive Retrospective Cohort Study to Evaluate the Incidence of Severe COVID 19 Outcomes Among sars-cov-2 Infected Patients in the United States
Judith Absalon
Favorite
Abu Esba, Laila

Pharmaceutical Care Department, Ministry of the National Guard, Health Affairs, Riyadh, Saudi Arabia
(P-081) Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
Laila Abu Esba
Favorite
AbuAlhommos, Amal Khaleel

Pharmacy Practice Department, Clinical Pharmacy College, King Faisal University
(P-158) The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study
Amal Khaleel AbuAlhommos
Favorite
Abuthawabeh, Rasha

Faculty of Pharmacy, Isra University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Rasha Abuthawabeh
Favorite
Acharya, Sahana

Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India
(P-566) Reporting of Pancreatitis with Tocilizumab Use: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System
Sahana Acharya
Favorite
Acurcio, Francisco

Federal University of Minas Gerais
(P-096) Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
Francisco Acurcio
Favorite
(P-394) Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
Francisco Acurcio
Favorite
Adams, Val

Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky
(P-491) Real- world Utilization of Octreotide Immediate Releasing Use with Octreotide Long-acting Releasing
Val Adams
Favorite
Adedapo, Aduragbenro

University of Ibadan
(P-494) Patterns of Antimicrobial Prescribed to Patients Admitted to a Tertiary Care Hospital in South-west Nigeria: A Prescription Quality Audit
Aduragbenro Adedapo
Favorite
Adgent, Margaret

Vanderbilt University Medical Center
(P-050) Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results
Margaret Adgent
Favorite
(P-537) Temporal and Hospital-level Variation in High-dose Postpartum Opioid Prescribing After Cesarean Delivery
Margaret Adgent
Favorite
(P-563) A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
Margaret Adgent
Favorite
Adkins, Lauren E

Health Science Center Libraries, University of Florida
(P-066) Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data
Lauren E Adkins
Favorite
(P-107) Evaluating the Use of Prescription Sequence Symmetry Analysis as a Pharmacovigilance Tool: A Scoping Review
Lauren E Adkins
Favorite
(P-231) Association Between Non-adherence to Endocrine Therapy and the Risk of Recurrence Among Breast Cancer Survivors: A Systematic Literature Review
Lauren E Adkins
Favorite
(P-232) Opioid Use Patterns Among Non-metastatic Cancer Survivors: A Systematic Literature Review
Lauren E Adkins
Favorite
Afriyie, Daniel

Ghana Police Hospital
(P-162) Key Opportunities and Future Direction for Drug Utilization Research in Africa
Daniel Afriyie
Favorite
Aguilar, Kathleen

Ontada, The Woodlands, TX
(P-574) Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
Kathleen Aguilar
Favorite
Ahmidi, Narges

Institute of Computational Biology, HelmholtzZentrum münchen
(P-521) Towards OS approximation in early clinical trials using Prognostic Scores
Narges Ahmidi
Favorite
Akici, Ahmet

Department of Medical Pharmacology, School of Medicine, Marmara University, Istanbul, Turkey
(P-105) Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
Ahmet Akici
Favorite
(P-489) Evaluation of Chirality for Withdrawn Drugs
Ahmet Akici
Favorite
Akici, Narin

Department of Pediatrics, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
(P-105) Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
Narin Akici
Favorite
Akunne, Onyinye

University of the Western Cape
(P-494) Patterns of Antimicrobial Prescribed to Patients Admitted to a Tertiary Care Hospital in South-west Nigeria: A Prescription Quality Audit
Onyinye Akunne
Favorite
Al Omar, Muaed

College of Pharmacy and Health Sciences, Ajman University
(P-175) Community Pharmacists Managed Patient Safety Program with Minimal Patient Contact for Elderly Patients in Ajman, United Arab Emirates
Muaed Al Omar
Favorite
Al Orf, Nora
(P-373) Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
Nora Al Orf
Favorite
Alaeddin, Nersi

Deutsches Zentrum f�r neurodegenerative Erkrankungen
(P-080) Validation of Self-reported Medication Use Applying Untargeted Mass Spectrometry-based Metabolomics Techniques in the Rhineland Study
Nersi Alaeddin
Favorite
Alalwan, Abdullah
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Abdullah Alalwan
Favorite
Alanazi, Tahani

Regional drug information center, Saudi Arabia .
(P-120) Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
Tahani Alanazi
Favorite
Alanazi, Turkiah

King Fahd Specialty Hospital
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Turkiah Alanazi
Favorite
Alarcon, Graciela

University of Alabama at Birmingham
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Graciela Alarcon
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Graciela Alarcon
Favorite
Albalawi, Omar

Saudi Food & Drug Authority (SFDA)
(P-420) The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia
Omar Albalawi
Favorite
Albano, Jessica

Syneos Health
(P-565) Recent Use of External Controls in Clinical Trials: A Pragmatic Literature Review
Jessica Albano
Favorite
Albert, Lisa

IQVIA
(P-508) COVID-19 Symptom Severity Among Smokers: Insights from a Direct-to-community Registry
Lisa Albert
Favorite
Albogami, Yasser

King Saud University
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Yasser Albogami
Favorite
Alcusky, Matthew

Division of Epidemiology, Department of Population and Quantitative Health Services, University of Massachusetts Medical School
(P-049) Prevalence and Factors Associated with Oral Anticoagulant Use in the General Nursing Home Population
Matthew Alcusky
Favorite
Aldayel, Atheer

Drug Safety and Risk Management Department, Saudi Food and Drug Authority. Riyadh, Saudi Arabia
(P-362) Post-marketing Drug Safety Sources: An Evaluation of the Fda’s Drug Safety Communications
Atheer Aldayel
Favorite
Alenzi, Khalidah

MOH in saudi
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Khalidah Alenzi
Favorite
(P-120) Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
Khalidah Alenzi
Favorite
Alenzi, Najah

Regional Drug Information and Pharmacovigilance Center, Ministry of Health, Tabuk, Saudi Arabia
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Najah Alenzi
Favorite
(P-120) Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
Najah Alenzi
Favorite
Alexander, G Caleb

Johns Hopkins Bloomberg School of Public Health
(P-357) Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
G Caleb Alexander
Favorite
(P-603) Prescription Drug-based Risk Scores: A Systematic Review
G Caleb Alexander
Favorite
(P-604) Risk of Hospitalization and Death Associated with Pimavanserin Use in Older Adults with Parkinson’s Disease
G Caleb Alexander
Favorite
AL-Fadel, Nouf

Saudi FDA
(P-020) Safety Review of Vemurafenib and Potential Risk of Hyperglycemia: A Systematic Review and Analysis of Individual Case Safety Reports in the WHO Global Database
Nouf AL-Fadel
Favorite
(P-021) Olanzapine and Potential Risk of Somnambulism : A Systematic Review
Nouf AL-Fadel
Favorite
(P-376) Dupilumab Use and Potential Risk of Alopecia Areata: A Systematic Review
Nouf AL-Fadel
Favorite
Alfian, Sofa

Groningen Research Institute of Pharmacy, University of Groningen
(P-058) Process Evaluation of Implementing a Pharmacist-led Intervention to Improve Adherence to Antihypertensive Drugs Among Patients with Type 2 Diabetes in Indonesian Community Health Centers
Sofa Alfian
Favorite
alGhamdi, Maha

Saudi Food and Drug Authority
(P-362) Post-marketing Drug Safety Sources: An Evaluation of the Fda’s Drug Safety Communications
Maha alGhamdi
Favorite
Alghamdi, Moshari

Regional drug information and pharmacovigilance center - staff - moh
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Moshari Alghamdi
Favorite
AlGhannam, Wed

Saudi Food and Drug Authority
(P-081) Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
Wed AlGhannam
Favorite
AL-Habardi, Saja

Saudi Food and Drug Authority
(P-020) Safety Review of Vemurafenib and Potential Risk of Hyperglycemia: A Systematic Review and Analysis of Individual Case Safety Reports in the WHO Global Database
Saja AL-Habardi
Favorite
(P-021) Olanzapine and Potential Risk of Somnambulism : A Systematic Review
Saja AL-Habardi
Favorite
Al-Hallaq, Ghaydaa Ramzi

Faculty of Pharmacy, Isra University
(P-134) Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
Ghaydaa Ramzi Al-Hallaq
Favorite
AL-Harbi, Fawaz

Drug Safety and Risk Management Department, Saudi Food and Drug Authority
(P-020) Safety Review of Vemurafenib and Potential Risk of Hyperglycemia: A Systematic Review and Analysis of Individual Case Safety Reports in the WHO Global Database
Fawaz AL-Harbi
Favorite
(P-021) Olanzapine and Potential Risk of Somnambulism : A Systematic Review
Fawaz AL-Harbi
Favorite
(P-081) Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
Fawaz AL-Harbi
Favorite
(P-362) Post-marketing Drug Safety Sources: An Evaluation of the Fda’s Drug Safety Communications
Fawaz AL-Harbi
Favorite
(P-373) Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
Fawaz AL-Harbi
Favorite
(P-376) Dupilumab Use and Potential Risk of Alopecia Areata: A Systematic Review
Fawaz AL-Harbi
Favorite
AlHarbi, Muhanad

The Saudi Food and Drug Authority
(P-363) Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
Muhanad AlHarbi
Favorite
(P-364) The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia
Muhanad AlHarbi
Favorite
(P-365) A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia
Muhanad AlHarbi
Favorite
Alhartani, Yosra J.

Faculty of Pharmacy, Isra University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Yosra J. Alhartani
Favorite
Alhossan, Abdulaziz

Department of Clinical Pharmacy, King Saud University, Saudi Arabia
(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
Abdulaziz Alhossan
Favorite
Alhusayni, Lama

Saudi Food and Drug Authority
(P-376) Dupilumab Use and Potential Risk of Alopecia Areata: A Systematic Review
Lama Alhusayni
Favorite
Aliabadi, Negar

Pfizer Inc.
(P-072) Deterministic Linkage of Pregnant Mothers and Their Newborns in Integrated US Insurance Claims and Electronic Health Record Data
Negar Aliabadi
Favorite
Ali, Ayad

Eli Lilly and Company
(P-039) Epidemiology of Interstitial Lung Disease in Medically Treated US Population
Ayad Ali
Favorite
(P-041) Scope of Insulin Human Utilization in Females of Childbearing Age in the US
Ayad Ali
Favorite
(P-042) Epidemiology of Coexisting Obesity and Heart Failure with Preserved Ejection Fraction in the United States
Ayad Ali
Favorite
(P-044) Epidemiology of COVID-19 in Children
Ayad Ali
Favorite
(P-045) Epidemiology of COVID-19 in Adults with Diabetes Mellitus
Ayad Ali
Favorite
(P-046) Epidemiology of COVID-19 in Adults with Asthma
Ayad Ali
Favorite
(P-048) Epidemiology of COVID-19 in Adults with Chronic Obstructive Pulmonary Disease
Ayad Ali
Favorite
Ali, Karrar Ehsan

Faculty of Pharmacy, Isra University
(P-158) The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study
Karrar Ehsan Ali
Favorite
Ali, Robert

Department of Pharmacology, University of Adelaide, Adelaide, Australia
(P-326) The Effect of Prescriber, Treatment, and Client Characteristics on Retention in Opioid Agonist Treatment: A 15-year Retrospective Cohort Study
Robert Ali
Favorite
Aljallal, Mohammed

Saudi Food & Drug Authority (SFDA)
(P-420) The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia
Mohammed Aljallal
Favorite
Aljrarri, Waad

Scientific Office, Boehringer Ingelheim, Riyadh, Saudi Arabia
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Waad Aljrarri
Favorite
Alkherb, Zakiyah

Central Drug Registration, Gulf Health Council, Riyadh, Saudi Arabia
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Zakiyah Alkherb
Favorite
Allen, Janis

Genentech, Inc.
(P-056) Genetic Heterogeneity Patterns of Electronic Medical Record (EMR)-Derived Race Groups in a Deidentified Clinico-genomic Database (CGDB)
Janis Allen
Favorite
Almaghrabi, Mona

Drug Safety and Risk Management Department, Saudi Food and Drug Authority. Riyadh, Saudi Arabia
(P-373) Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
Mona Almaghrabi
Favorite
Almalki, Mohammed

Umluj hospital -Ministry of health
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Mohammed Almalki
Favorite
Almansour, Hadi

School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
(P-151) Socio-epidemiological Approaches in Designing and Modelling Pharmacy Public Health Programs in Infectious Diseases Control in Developing Countries
Hadi Almansour
Favorite
(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
Hadi Almansour
Favorite
Almas, Mariana

IQVIA
(P-278) A Review of the Sampling Methodology Used in Studies Evaluating the Effectiveness of Risk Minimization Measures in Europe
Mariana Almas
Favorite
(P-596) Insights from a Review of Publicly Available Information on Post Authorisation Safety Studies (PASS)
Mariana Almas
Favorite
Almeida-Brasil, Celline

Research Institute of the McGill University Health Centre
(P-524) Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis
Celline Almeida-Brasil
Favorite
(P-525) Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
Celline Almeida-Brasil
Favorite
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Celline Almeida-Brasil
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Celline Almeida-Brasil
Favorite
Almutairi, Abdulaali

Drug Safety and Risk Management Department, Saudi Food and Drug Authority. Riyadh, Saudi Arabia
(P-362) Post-marketing Drug Safety Sources: An Evaluation of the Fda’s Drug Safety Communications
Abdulaali Almutairi
Favorite
(P-373) Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
Abdulaali Almutairi
Favorite
Alnakhibe, Monirah

Duba hospital
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Monirah Alnakhibe
Favorite
Alnuaim, Abdulrahman

Saudi Food and Drug Authority (SFDA)
(P-363) Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
Abdulrahman Alnuaim
Favorite
Alolayet, Rayan

County Government of Laikipia
(P-363) Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
Rayan Alolayet
Favorite
(P-364) The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia
Rayan Alolayet
Favorite
Alomrani, Hamod

General Haql Hospital , MOH , Saudi Arabia
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Hamod Alomrani
Favorite
Alotaibi, Basil

College of Pharmacy, King Saud University
(P-136) Prevalence of Chronic Kidney Diseases in Patients with Diabetes Mellitus in the Middle East: A Systematic Review and Meta-analysis
Basil Alotaibi
Favorite
(P-137) Predictors of Length of Stay, Mortality and Outcomes Among Hospitalised COVID-19 Patients In saudi Arabia
Basil Alotaibi
Favorite
Alper, Jeffrey

Medallion Clinical Research Institute, LLC
(P-124) Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-based Network
Jeffrey Alper
Favorite
AlQadheeb, Eman

Saudi Food and Drug and Authority
(P-364) The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia
Eman AlQadheeb
Favorite
(P-365) A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia
Eman AlQadheeb
Favorite
Alqahtani, Amani

Saudi Food & Drug Authority (SFDA)
(P-420) The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia
Amani Alqahtani
Favorite
Alqubali, Fawziah

King Khalid hospital
(P-119) Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
Fawziah Alqubali
Favorite
Alrasheed, Marwan

University of Cincinnati, College of Pharmacy
(P-200) Safety Evaluation of Panobinostat, Ixazomib, Elotuzumab, and Daratumumab Using FDA Adverse Event Reporting System (FAERS) Database 2015 – 2020
Marwan Alrasheed
Favorite
(P-201) Comparison of Quality of Life Between Men and Women with Chronic Liver Diseases Using Chronic Liver Disease Questionnaire (CLDQ): A Meta-analysis
Marwan Alrasheed
Favorite
Alrasheed, Meshael
(P-420) The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia
Meshael Alrasheed
Favorite
Alrawashdeh, Hamzeh

Amman Eye Clinic
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Hamzeh Alrawashdeh
Favorite
Alrousan, Rabaa

Faculty of Pharmacy, Isra University
(P-158) The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study
Rabaa Alrousan
Favorite
Alrubaish, Fares

Drug Safety and Risk Management Department, Saudi Food and Drug Authority
(P-081) Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
Fares Alrubaish
Favorite
Alrwisan, Adel

Saudi Food and Drug Authority, Riyadh, Saudi Arabia
(P-081) Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
Adel Alrwisan
Favorite
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Adel Alrwisan
Favorite
Alshahrani, Amani

College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
(P-440) The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
Amani Alshahrani
Favorite
Al-Shahrani, Mobarak

The Saudi Food and Drug Authority
(P-363) Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
Mobarak Al-Shahrani
Favorite
(P-364) The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia
Mobarak Al-Shahrani
Favorite
(P-365) A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia
Mobarak Al-Shahrani
Favorite
Alshammari, Faizah

University of Hail
(P-442) Medication Error Concept and Reporting Practices in Saudi Arabia: A Nationwide Study Among Healthcare Professionals
Faizah Alshammari
Favorite
Alshammari, Thamir M.

College of Pharmacy, Riyadh Elm University
(P-120) Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
Thamir M. Alshammari
Favorite
(P-442) Medication Error Concept and Reporting Practices in Saudi Arabia: A Nationwide Study Among Healthcare Professionals
Thamir M. Alshammari
Favorite
Alsuhibani, Abdulrahman

James L. Winkle College of Pharmacy, University Of Cincinnati
(P-200) Safety Evaluation of Panobinostat, Ixazomib, Elotuzumab, and Daratumumab Using FDA Adverse Event Reporting System (FAERS) Database 2015 – 2020
Abdulrahman Alsuhibani
Favorite
(P-201) Comparison of Quality of Life Between Men and Women with Chronic Liver Diseases Using Chronic Liver Disease Questionnaire (CLDQ): A Meta-analysis
Abdulrahman Alsuhibani
Favorite
Alsulaiman, Ali

King Khalid Hospital in Najran
(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
Ali Alsulaiman
Favorite
AlSultan, Mohammed
(P-266) Effectiveness and Safety of Edoxaban and Warfarin in Nonvalvular Atrial Fibrillation Patients: A Meta-analysis of Real-world Studies
Mohammed AlSultan
Favorite
Alswar, Ahmed

King Khalid Hospital in Najran, Saudi Arabia
(P-406) Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
Ahmed Alswar
Favorite
AL-Tayyar, Waad

Saudi FDA
(P-021) Olanzapine and Potential Risk of Somnambulism : A Systematic Review
Waad AL-Tayyar
Favorite
Altebainawi, Ali

Ministry of Health
(P-120) Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
Ali Altebainawi
Favorite
Alvares-Teodoro, Juliana

Federal University of Minas Gerais
(P-096) Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
Juliana Alvares-Teodoro
Favorite
(P-394) Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
Juliana Alvares-Teodoro
Favorite
Alwafi, Danya

Department of Dermatology, King Abdulaziz Medical City
(P-134) Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
Danya Alwafi
Favorite
Alwafi, Hassan

Faculty of Medicine, Umm Alqura University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Hassan Alwafi
Favorite
(P-134) Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
Hassan Alwafi
Favorite
(P-135) Depression and Anxiety in Patients with Cancer: Prevalence and Risk Factors: A Cross-sectional Study
Hassan Alwafi
Favorite
(P-136) Prevalence of Chronic Kidney Diseases in Patients with Diabetes Mellitus in the Middle East: A Systematic Review and Meta-analysis
Hassan Alwafi
Favorite
(P-137) Predictors of Length of Stay, Mortality and Outcomes Among Hospitalised COVID-19 Patients In saudi Arabia
Hassan Alwafi
Favorite
(P-158) The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study
Hassan Alwafi
Favorite
(P-319) Prevalence of Adverse Drug Reactions in the Primary Care Setting: A Systematic Review and Meta-analysis
Hassan Alwafi
Favorite
Alwan, Salwan Salah

Faculty of Pharmacy, Isra University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Salwan Salah Alwan
Favorite
Alyami, Fatimah

University of Cincinnati, College of Pharmacy
(P-215) Safety Profile Analysis of Sunitinib and Dasatinib Protein Kinase Inhibitors Using FDA Adverse Event Reporting System (FAERS) Database
Fatimah Alyami
Favorite
Alyami, Mohammad H.

Department of Pharmaceutics, College of Pharmacy, Najran University
(P-131) Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
Mohammad H. Alyami
Favorite
Aman, Usman

Tmunity Therapeutics
(P-451) Creating High Quality External Control Arms from RWD in Support of Regulatory Decision Making
Usman Aman
Favorite
Ambrosecchia, Shara

SpecGx LLC (a wholly owned subsidiary of Mallinckrodt LLC)
(P-206) Pediatric Fentanyl Overdose Within an Electronic Health Record Database
Shara Ambrosecchia
Favorite
Ambroz, Martina

University Medical Center Groningen
(P-008) Sex Differences in Lipid Profile Across the Life Span in Patients with Type 2 Diabetes: A Cross-sectional Study
Martina Ambroz
Favorite
Andersen, Morten

Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen
(P-632) Comparison of the Incidence of Acute Pancreatitis Among New Users of Fluoxetine, Citalopram, and Other Selective Serotonin Reuptake Inhibitors: A Danish Register-based Cohort Study
Morten Andersen
Favorite
Andrea, Spini

University of Siena
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Spini Andrea
Favorite
(P-414) Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany
Spini Andrea
Favorite
Andrić, Adriana

Agency for Medicinal Products and Medical Devices of Croatia (HALMED), Croatia
(P-062) Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study Among Healthcare Professionals and Patients in Croatia, the Netherlands, and the UK
Adriana Andrić
Favorite
An, Huijun

Johns Hopkins University
(P-357) Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
Huijun An
Favorite
(P-604) Risk of Hospitalization and Death Associated with Pimavanserin Use in Older Adults with Parkinson’s Disease
Huijun An
Favorite
Annis, Izabela

Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
(P-400) Imbalanced Data Bias in Logistic Regression to Estimate Treatment Effects: Results from a Virtual Patient Cohort Simulation
Izabela Annis
Favorite
Ann, Quratul

IQVIA Ltd.
(P-341) Methodological Considerations Related to the Use of Primary and Secondary Care Data in Identifying a Cohort of Moderate to Severe Psoriasis Patients in the UK
Quratul Ann
Favorite
Anthony, Lowell

Department of Internal Medicine & Divisions-Medical Oncology, College of Medicine, University of Kentucky
(P-491) Real- world Utilization of Octreotide Immediate Releasing Use with Octreotide Long-acting Releasing
Lowell Anthony
Favorite
Antonazzo, Ippazio Cosimo

University of Milan - Bicocca
(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
Ippazio Cosimo Antonazzo
Favorite
Antonelli, Patrick

Department of Otolaryngology, University of Florida College of Medicine
(P-098) Risk of Intracranial Meningioma Requiring Surgical Intervention Among Recent Hormonal Contraceptives Users
Patrick Antonelli
Favorite
Aparasu, Rajender

University of Houston
(P-293) Factors Associated with Different Dosage Forms of Disease-modifying Agents in Older Adults with Multiple Sclerosis
Rajender Aparasu
Favorite
Araújo, Amanda

UFOP - Universidade Federal de Ouro Preto
(P-553) Pharmacists Role in Patient Safety: Evaluation of Dispensing Errors in a Regional Hospital
Amanda Araújo
Favorite
Aragon, Maria

Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona , Spain
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Maria Aragon
Favorite
(P-567) SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
Maria Aragon
Favorite
Aranow, Cynthia

Feinstein Institute for Medical Research
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Cynthia Aranow
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Cynthia Aranow
Favorite
Araujo, Mélanie

Réseau REGARDS, Laboratoire de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, Faculté de Médecine de l'Université Paul-Sabatier, UMR INSERM 1295, CERPOP
(P-238) Risk of Domperidone in Pregnant Women: A Study in the EFEMERIS Database
Mélanie Araujo
Favorite
Ardeshirrouhanifard, Shirin

Bloomberg School of Public Health, Johns Hopkins University
(P-357) Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
Shirin Ardeshirrouhanifard
Favorite
Ariant, Zinedine Yusuf

Faculty of Medicine, Universitas Islam Indonesia
(P-152) The Use of Medication Among People with Stage 2 Hypertension: Findings from an Indonesian Cross-sectional Study
Zinedine Yusuf Ariant
Favorite
Armaroli, Annarita

Center of Epidemiology for Clinical Research,University of Ferrara Azienda Ospedaliero- Universitaria di Ferrara
(P-071) Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
Annarita Armaroli
Favorite
Arora, Malika

Indian Council of Medical Research Scientist-l, Multidisciplinary Research Unit (Department of Health Research, Government of India), Guru Gobind Singh Medical College, Faridkot, Punjab, India- 151203
(P-184) Prevalence and Predictors of Potentially Inappropriate Psychotropic (PIP) Medications in Older Adults with Psychiatric Illness
Malika Arora
Favorite
(P-185) Prevalence of Potentially Inappropriate Medication and Its Correlates in Elderly Hospitalized Patients: A Cross‑sectional Study Based on Beers Criteria
Malika Arora
Favorite
(P-186) Prevalence of Potentially Inappropriate Medication in Elderly Inpatients with Chronic Kidney Disease (CKD)
Malika Arora
Favorite
Ascobat, Purwantyastuti

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Indonesia, Jakarta
(P-410) The Effectiveness of a Module for Primary Health Care Professionals in Preventing Nonsteroidal Anti-inflammatory Drugs-associated Gastrointestinal Adverse Reactions Among Elderly
Purwantyastuti Ascobat
Favorite
Askanase, Anca

Columbia University Medical Centre
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Anca Askanase
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Anca Askanase
Favorite
Atac, Omer

Department of Public Health, School of Medicine, Istanbul Medipol University, Istanbul, Turkey
(P-105) Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
Omer Atac
Favorite
Atif, Muhammad

Department of Pharmacy Practice, The Islamia University of Bahawalpur
(P-470) Antibiotic Resistance Pattern and Treatment Outcomes Among Empyema Thoracis Patients: A Cross-sectional Study
Muhammad Atif
Favorite
Attalla, Marian

Uppsala Monitoring Centre
(P-061) Montelukast and Nightmare – Further Characterisation Using Data from Vigibase
Marian Attalla
Favorite
Attinson, Dionna

Aetion, Inc
(P-378) A Counterfactual Approach to Minimize Channeling Bias in Post-market Safety Surveillance
Dionna Attinson
Favorite
(P-379) Propensity Score Modeling to Reduce Channeling Bias When Exposure Is Rare
Dionna Attinson
Favorite
Au, Philip C.-M.

Researcher
(P-533) PD-1 Immune Checkpoint Inhibitors and Serious Immune-related Adverse Events
Philip C.-M. Au
Favorite
Aydin, Volkan

Department of Medical Pharmacology, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey
(P-105) Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
Volkan Aydin
Favorite
(P-489) Evaluation of Chirality for Withdrawn Drugs
Volkan Aydin
Favorite
Ayele, Henok Tadesse

Merck & Co., Inc.
(P-498) Sulfonylureas and the Risk of Ventricular Arrhythmias Among Patients with Type 2 Diabetes: A Systematic Review of Observational Studies
Henok Tadesse Ayele
Favorite
(P-580) 5-alpha Reductase Inhibitors and the Risk of Anemia Among Men with Benign Prostatic Hyperplasia
Henok Tadesse Ayele
Favorite
Azoulay, Laurent

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Québec, Canada
(P-126) The Use of Lag Times in Cancer Pharmacoepidemiology
Laurent Azoulay
Favorite
(P-529) Treatment Trajectory of Antihypertensive Drugs in UK Primary Care Practices
Laurent Azoulay
Favorite
(P-540) The Association Between Type 2 Diabetes and Cancer Incidence in the United Kingdom Between 1988 and 2019
Laurent Azoulay
Favorite
(P-617) Use of Renin-angiotensin-aldosterone System Inhibitors and the Risk of Acute Pancreatitis
Laurent Azoulay
Favorite
AZZOUZ, Brahim

Univerity of Reims
(P-308) Penetration Rate of Anti-tnf Biosimilars in Hospitals in France: 5 Years Status
Brahim AZZOUZ
Favorite
(P-309) Psoriasis Risk After Betablockers Exposure: Analysis of French Pharmacovigilance Data
Brahim AZZOUZ
Favorite